Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 10 studies | 25% ± 8% | |
CD4-positive, alpha-beta T cell | 10 studies | 27% ± 11% | |
macrophage | 7 studies | 21% ± 7% | |
classical monocyte | 6 studies | 22% ± 5% | |
CD8-positive, alpha-beta T cell | 6 studies | 22% ± 5% | |
mucosal invariant T cell | 5 studies | 26% ± 8% | |
myeloid cell | 4 studies | 28% ± 8% | |
natural killer cell | 4 studies | 24% ± 8% | |
regulatory T cell | 4 studies | 29% ± 7% | |
CD4-positive, alpha-beta memory T cell | 4 studies | 27% ± 8% | |
monocyte | 3 studies | 22% ± 5% | |
conventional dendritic cell | 3 studies | 22% ± 5% | |
effector CD4-positive, alpha-beta T cell | 3 studies | 25% ± 5% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 25% ± 7% | |
T-helper 1 cell | 3 studies | 43% ± 18% |
Insufficient scRNA-seq data for expression of TNF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 259.21 | 558 / 578 | 55% | 4.31 | 639 / 1155 |
breast | 59% | 48.30 | 270 / 459 | 66% | 5.41 | 741 / 1118 |
kidney | 90% | 86.04 | 80 / 89 | 31% | 1.57 | 281 / 901 |
intestine | 77% | 82.57 | 739 / 966 | 43% | 2.09 | 229 / 527 |
esophagus | 58% | 29.04 | 833 / 1445 | 50% | 6.45 | 91 / 183 |
skin | 67% | 67.93 | 1219 / 1809 | 34% | 1.93 | 159 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.26 | 29 / 29 |
spleen | 100% | 505.06 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1616.67 | 918 / 929 | 0% | 0 | 0 / 0 |
stomach | 53% | 31.66 | 189 / 359 | 42% | 1.93 | 120 / 286 |
ovary | 7% | 2.40 | 12 / 180 | 84% | 14.36 | 362 / 430 |
adrenal gland | 77% | 44.07 | 199 / 258 | 10% | 0.37 | 22 / 230 |
tonsil | 0% | 0 | 0 / 0 | 84% | 8.31 | 38 / 45 |
uterus | 22% | 7.33 | 37 / 170 | 61% | 7.12 | 282 / 459 |
bladder | 38% | 12.24 | 8 / 21 | 40% | 2.92 | 202 / 504 |
pancreas | 30% | 11.21 | 98 / 328 | 46% | 2.33 | 82 / 178 |
brain | 17% | 8.43 | 460 / 2642 | 58% | 7.01 | 412 / 705 |
heart | 68% | 58.91 | 584 / 861 | 0% | 0 | 0 / 0 |
liver | 56% | 25.41 | 127 / 226 | 8% | 0.57 | 33 / 406 |
adipose | 57% | 54.64 | 688 / 1204 | 0% | 0 | 0 / 0 |
thymus | 34% | 18.41 | 224 / 653 | 21% | 1.43 | 130 / 605 |
prostate | 29% | 10.57 | 70 / 245 | 9% | 0.32 | 44 / 502 |
blood vessel | 35% | 23.20 | 463 / 1335 | 0% | 0 | 0 / 0 |
muscle | 9% | 2.43 | 74 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.15 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0090594 | Biological process | inflammatory response to wounding |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_1902565 | Biological process | positive regulation of neutrophil activation |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0006954 | Biological process | inflammatory response |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0031642 | Biological process | negative regulation of myelination |
GO_0150129 | Biological process | positive regulation of interleukin-33 production |
GO_0009651 | Biological process | response to salt stress |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0048566 | Biological process | embryonic digestive tract development |
GO_1903347 | Biological process | negative regulation of bicellular tight junction assembly |
GO_0010459 | Biological process | negative regulation of heart rate |
GO_0060693 | Biological process | regulation of branching involved in salivary gland morphogenesis |
GO_0002637 | Biological process | regulation of immunoglobulin production |
GO_0014823 | Biological process | response to activity |
GO_0045994 | Biological process | positive regulation of translational initiation by iron |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0043537 | Biological process | negative regulation of blood vessel endothelial cell migration |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0006959 | Biological process | humoral immune response |
GO_0009750 | Biological process | response to fructose |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0090324 | Biological process | negative regulation of oxidative phosphorylation |
GO_0045760 | Biological process | positive regulation of action potential |
GO_0032741 | Biological process | positive regulation of interleukin-18 production |
GO_0001666 | Biological process | response to hypoxia |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0045598 | Biological process | regulation of fat cell differentiation |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1904996 | Biological process | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0060557 | Biological process | positive regulation of vitamin D biosynthetic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0006006 | Biological process | glucose metabolic process |
GO_0043243 | Biological process | positive regulation of protein-containing complex disassembly |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0010573 | Biological process | vascular endothelial growth factor production |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1904999 | Biological process | positive regulation of leukocyte adhesion to arterial endothelial cell |
GO_0031622 | Biological process | positive regulation of fever generation |
GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
GO_0002925 | Biological process | positive regulation of humoral immune response mediated by circulating immunoglobulin |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_1905038 | Biological process | regulation of membrane lipid metabolic process |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0060252 | Biological process | positive regulation of glial cell proliferation |
GO_0035509 | Biological process | negative regulation of myosin-light-chain-phosphatase activity |
GO_0048143 | Biological process | astrocyte activation |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0002523 | Biological process | leukocyte migration involved in inflammatory response |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_2000343 | Biological process | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0072577 | Biological process | endothelial cell apoptotic process |
GO_0060559 | Biological process | positive regulation of calcidiol 1-monooxygenase activity |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0030730 | Biological process | sequestering of triglyceride |
GO_0050807 | Biological process | regulation of synapse organization |
GO_0002876 | Biological process | positive regulation of chronic inflammatory response to antigenic stimulus |
GO_2000351 | Biological process | regulation of endothelial cell apoptotic process |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0097421 | Biological process | liver regeneration |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0043068 | Biological process | positive regulation of programmed cell death |
GO_2000573 | Biological process | positive regulation of DNA biosynthetic process |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0050901 | Biological process | leukocyte tethering or rolling |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0002281 | Biological process | macrophage activation involved in immune response |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_1902065 | Biological process | response to L-glutamate |
GO_0002719 | Biological process | negative regulation of cytokine production involved in immune response |
GO_1900222 | Biological process | negative regulation of amyloid-beta clearance |
GO_0002439 | Biological process | chronic inflammatory response to antigenic stimulus |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0071803 | Biological process | positive regulation of podosome assembly |
GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
GO_2000347 | Biological process | positive regulation of hepatocyte proliferation |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_1990268 | Biological process | response to gold nanoparticle |
GO_0001774 | Biological process | microglial cell activation |
GO_0060664 | Biological process | epithelial cell proliferation involved in salivary gland morphogenesis |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_2000272 | Biological process | negative regulation of signaling receptor activity |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0035900 | Biological process | response to isolation stress |
GO_0050966 | Biological process | detection of mechanical stimulus involved in sensory perception of pain |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0045471 | Biological process | response to ethanol |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0003085 | Biological process | negative regulation of systemic arterial blood pressure |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0051222 | Biological process | positive regulation of protein transport |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_1901647 | Biological process | positive regulation of synoviocyte proliferation |
GO_1903721 | Biological process | positive regulation of I-kappaB phosphorylation |
GO_0034116 | Biological process | positive regulation of heterotypic cell-cell adhesion |
GO_0061048 | Biological process | negative regulation of branching involved in lung morphogenesis |
GO_0150078 | Biological process | positive regulation of neuroinflammatory response |
GO_0050806 | Biological process | positive regulation of synaptic transmission |
GO_2000334 | Biological process | positive regulation of blood microparticle formation |
GO_0010888 | Biological process | negative regulation of lipid storage |
GO_0042311 | Biological process | vasodilation |
GO_0032724 | Biological process | positive regulation of fractalkine production |
GO_1903140 | Biological process | regulation of establishment of endothelial barrier |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0061044 | Biological process | negative regulation of vascular wound healing |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0043507 | Biological process | positive regulation of JUN kinase activity |
GO_0036005 | Biological process | response to macrophage colony-stimulating factor |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0009615 | Biological process | response to virus |
GO_0120190 | Biological process | negative regulation of bile acid secretion |
GO_0030198 | Biological process | extracellular matrix organization |
GO_1905242 | Biological process | response to 3,3',5-triiodo-L-thyronine |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0051798 | Biological process | positive regulation of hair follicle development |
GO_0007623 | Biological process | circadian rhythm |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0031667 | Biological process | response to nutrient levels |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0140460 | Biological process | response to Gram-negative bacterium |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0043242 | Biological process | negative regulation of protein-containing complex disassembly |
GO_0071677 | Biological process | positive regulation of mononuclear cell migration |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0097527 | Biological process | necroptotic signaling pathway |
GO_0050890 | Biological process | cognition |
GO_0071316 | Biological process | cellular response to nicotine |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0097237 | Biological process | cellular response to toxic substance |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0030866 | Biological process | cortical actin cytoskeleton organization |
GO_0019222 | Biological process | regulation of metabolic process |
GO_0050768 | Biological process | negative regulation of neurogenesis |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0002037 | Biological process | negative regulation of L-glutamate import across plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0043025 | Cellular component | neuronal cell body |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0001891 | Cellular component | phagocytic cup |
GO_0042802 | Molecular function | identical protein binding |
GO_0005164 | Molecular function | tumor necrosis factor receptor binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
GO_0038177 | Molecular function | death receptor agonist activity |
Gene name | TNF |
Protein name | Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] Tumor necrosis factor (TNF-a) (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) [Cleaved into: Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] |
Synonyms | TNF-alpha hCG_43716 TNLG1F TNFA TNFSF2 |
Description | FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Impairs regulatory T-cells (Treg) function in individuals with rheumatoid arthritis via FOXP3 dephosphorylation. Up-regulates the expression of protein phosphatase 1 (PP1), which dephosphorylates the key 'Ser-418' residue of FOXP3, thereby inactivating FOXP3 and rendering Treg cells functionally defective . Key mediator of cell death in the anticancer action of BCG-stimulated neutrophils in combination with DIABLO/SMAC mimetic in the RT4v6 bladder cancer cell line . Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance (By similarity). Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6 . Promotes osteoclastogenesis and therefore mediates bone resorption (By similarity). .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . FUNCTION: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. .; FUNCTION: The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells. . |
Accessions | A0A8V8TNL2 ENST00000448781.2 ENST00000443707.2 ENST00000420425.2 A0A140T922 B5BUQ6 P01375 ENST00000445232.2 ENST00000449264.3 A0A0G2YPN5 ENST00000412275.2 ENST00000376122.3 Q5STB3 A0A977WMN2 C1K3N5 ENST00000699334.1 ENST00000383496.4 |